These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1096120)

  • 41. Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
    Hua AS; Macdonald IM; Myers JB; Fang P; Kincaid-Smith P
    Med J Aust; 1977 Jul; 2(1):5-9. PubMed ID: 331040
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of essential hypertension with trimazosin, a new vasodilator agent.
    Vlachakis ND; Mendlowitz M; De Guzman de Guzman D
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):564-9. PubMed ID: 808379
    [No Abstract]   [Full Text] [Related]  

  • 43. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of trimazosin in essential hypertension.
    De Gula D; Mendlowitz M; Russo C; Vlachakis ND; Antram S
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):339-48. PubMed ID: 4198294
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 46. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M
    Ugeskr Laeger; 1973 May; 135(20):974-6. PubMed ID: 4585571
    [No Abstract]   [Full Text] [Related]  

  • 48. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 49. Prazosin: preliminary report and comparative studies with other antihypertensive agents.
    Stokes GS; Weber MA
    Br Med J; 1974 May; 2(5914):298-300. PubMed ID: 4597121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
    Traub YM
    Arch Intern Med; 1988 Jan; 148(1):77-80. PubMed ID: 3276279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antihypertensive effects of metolazone (zaroxolyn).
    Materson BJ; Oster JR; Perez-Stable EC
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):890-6. PubMed ID: 4214663
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of hypertension in the elderly with special reference to urapidil.
    Hansson L
    Blood Press Suppl; 1994; 4():45-8. PubMed ID: 7804512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V
    Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methyldopa: single daily dose versus multiple daily dose.
    Yang C; Gurwich E; Kanada S; Nascimento L
    Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of hypertensive crisis with ebrantil (urapidil)].
    Mleczko-Nycz Z; Kokot F
    Wiad Lek; 1984 Jun; 37(11):817-20. PubMed ID: 6390979
    [No Abstract]   [Full Text] [Related]  

  • 58. [The hypotensive effect of prazosin].
    Huysmans FT; Thien T; Rosier JG; van't Laar A; Koene RA
    Ned Tijdschr Geneeskd; 1980 Jul; 124(28):1141-7. PubMed ID: 7402391
    [No Abstract]   [Full Text] [Related]  

  • 59. [Changes in left ventricular function and structure in hypertensive patients treated with methyldopa and urapidil].
    Rakić D; Rumboldt Z; Polić S; Obad M; Bagatin J
    Lijec Vjesn; 1990; 112(3-4):89-94. PubMed ID: 2204776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diurnal blood-pressure profile under Polypress therapy].
    Kirchhoff HW
    MMW Munch Med Wochenschr; 1982 Jul; 124(29-30):679-81. PubMed ID: 6126809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.